Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Ionis Pharmaceuticals, Inc. (IONS) had Normalized Pre-Tax Income of $141.84M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$452.05M |
|
$123.55M |
|
$4.15M |
|
$447.90M |
|
$312.23M |
|
$139.82M |
|
$-16.29M |
|
$123.53M |
|
|
Normalized Pre-Tax Income |
$141.84M |
$123.55M |
|
$123.55M |
|
$123.55M |
|
$141.86M |
|
$139.82M |
|
$141.05M |
|
159.14M |
|
182.33M |
|
$0.78 |
|
$0.70 |
|
| Balance Sheet Financials | |
$2.58B |
|
$111.95M |
|
$407.98M |
|
$2.99B |
|
$897.24M |
|
$625.49M |
|
$1.46B |
|
$2.35B |
|
$631.72M |
|
$631.72M |
|
$631.72M |
|
159.20M |
|
| Cash Flow Statement Financials | |
$0.56M |
|
$50.39M |
|
$3.45M |
|
$242.08M |
|
$297.30M |
|
$55.23M |
|
$59.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.87 |
|
-- |
|
-- |
|
0.50 |
|
1.99 |
|
99.08% |
|
30.93% |
|
30.93% |
|
-- |
|
27.33% |
|
27.33% |
|
$-24.32M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.49 |
|
8.60 |
|
10.47 |
|
19.56% |
|
19.56% |
|
4.14% |
|
9.83% |
|
$3.97 |
|
$-0.13 |
|
$0.00 |
|